References
- 1. Townsend N, Vogel C, Allender S, Halloran A, Sorensen K, Wilding J, et all. World Health Organization European Regional Obesity Report. Copenhaga (Danemarca), 2022. p. 1-2.
- 2. Bolsoni-Lopez A, Furieri Barros L, Cardoso Alonso Vale MI. Obesity and Covid-19: a reflection on the relationship between pandemics. Rev Gaucha Enferm. 2021; 42(spe):e20200216. doi:https://doi.org/10.1590/1983-1447.2021.2020021633787725
- 3. Ritter A, Kreis NN, Louwen, Yuan J. Obesity and COVID-19: Molecular mechanisms linking both pandemics. PubMed Central. 2020;21(16): 5793. doi: 10.3390/ijms21165793746084932806722
- 4. Sudhakar M, Winfred SB, Meiyazhagan G, Venkatachalam DP. Mechanisms contributing to adverse outcomes of COVID-19 in obesity. Mol Cell Biochem. 2022;477, p.1155-1193. Doi: https://doi.org/10.1007/s11010-022-04356-w879309635084674
- 5. Farzi R, Aghbash PS, Eslami N, Azadi A, Shamekh A, Hemmat N, et all. The role of antigen-presenting cells in the pathogenesis of COVID-19. PubMed Central. 2022;233:153848. doi: 10.1016/j. prp.2022.153848
- 6. Dicker D, Golan R, Baker JL, Busetto L, Fruhbeck G, Goossens GH, et all. Vaccinating people with obesity for COVID-19: EASO call for action. PubMed Central. 2021;14(3): 334-335. doi: 10.1159/000516524825563933915546
- 7. Chirila S, Hangan T, Gurgas L. BMI Calculator in Microsoft Excel. ARS Medica Tomitana. 2011;17(4):70-7.
- 8. Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et all. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. PubMed Central. 2020;133(9), p.1032-1038. Doi: 10.1097/CM9.0000000000000775714727932118640
- 9. Anderson M, Geleris J, Anderson D, Zucker J, Nobel YR, Freedberg D et all, Body Mass Index and risk for intubation or death in SARS-COV2 Infection. American College of Physicians Journals. 2020;173(10), p.782-790. Doi: https://doi.org/10.7326/M20-3214739755032726151
- 10. Garg S, Kim L, Whitaker M, Cummings C, Holstein R, Prill M et all. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 – COVID-NET, 14 states, March 1-30. MMWR Morb. Mortal. Wkly Rep. 2020;69(15):458–464. DOI: 10.15585/mmwr.mm6915e3775506332298251
- 11. Utku AC, Budak G, Karabay O, Guclu E, Okan HD, Vatan Asli. Main symptoms in patients presenting in the COVID-19 period. Scott Med J, 2020:0036933020949253. doi: 10.1177/0036933020949253868546932807018
- 12. Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, et all. Clinical features of COVID-19 and factors associated with severe clinical course: A systematic review and meta-analysis. SSRN. 2020. doi: 10.2139/ssrn.3566166736681532714109
- 13. Adebisi YA, Jimoh ND, Ogunkola IO, Uwizeyimana T, Olayemi AH, Ukor NA, et all. The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries. Trop Med Health. 2021;49:51. Doi: https://doi.org/10.1186/s41182-021-00344-w822011234162445
- 14. Yan H, Vijay A, Jiang F, Zheng N, Hu Y, Ye H, et all. Serum glucose, lactate dehydrogenase and hypertension are mediators of the effect of body mass index on severity of COVI-19. Endocrinol Diabetes Metab. 2021;4(2): e00215. Doi: 10.1002/edm2.215799499033851033
- 15. McNeill JN, Lau ES, Paniagua SM, Liu EE, Wang JK, Bassett IV, et all. The role of obesity in inflammatory markers in COVID-19 patients. Obes Res Clin Pract. 2021;15(1): 96-99. doi: 10.1016/j.orcp.2020.12.004783389833390322
- 16. Mehanna O, Askary AE, Ali E, Esawy BE, FathAlla T, Gharib AF. Impact of obesity and its associated comorbid conditions on COVID-19 presentation. Diabetes Metab Syndr Obes. 2021;14: 409-415. doi: 10.2147/DMSO.S287779785343133542640
- 17. Wu S, Zhou K, Hebert AM, Bena J, Kashyap S. Impact of metabolic Syndrome on severity of COVID-19 illness. Met Syndr and Related Disorders. 2022; 20(4): 191-198. Doi: https://doi.org/10.1089/met.2021.010234995147